Recruiting

Video-Guided Acupuncture Imagery for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Video-Guided Acupuncture Imagery Treatment (VGAIT)

Other
Who is being recruted

From 18 to 80 Years
+9 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: January 2026
See protocol details

Summary

Principal SponsorMassachusetts General Hospital
Study ContactSierra HodgesMore contacts
Last updated: February 11, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: January 6, 2026

Actual date on which the first participant was enrolled.

The study aims to explore a new approach called Video-Guided Acupuncture Imagery Treatment (VGAIT) to help people with breast cancer who have ongoing problems with nerve pain or numbness after chemotherapy, known as chemotherapy-induced peripheral neuropathy (CIPN). This condition often affects patients' quality of life, and finding effective ways to manage it is important. The study targets individuals with stage I-III breast cancer who continue to experience these symptoms despite completing their chemotherapy. By investigating VGAIT, the study hopes to offer a potential new method to alleviate the discomfort associated with CIPN. Participants in the study will undergo 16 sessions of VGAIT over a period of 8 weeks, conducted remotely via Zoom. The treatment involves guided imagery, which is a technique that uses visualization to help manage pain and discomfort. Researchers will evaluate how well participants continue with the treatment, how satisfied they are with this new method, and whether they complete all the study assessments. These factors will help determine the feasibility of using VGAIT for managing CIPN. The study measures are taken at the beginning, halfway through, and at the end of the 8-week period to assess the progress and effectiveness of the treatment.

Official TitleVideo-Guided Acupuncture Imagery Treatment in Chemotherapy-induced Peripheral Neuropathy
Principal SponsorMassachusetts General Hospital
Study ContactSierra HodgesMore contacts
Last updated: February 11, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

20 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Female

Biological sex of participants that are eligible to enroll.

From 18 to 80 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

4 inclusion criteria required to participate
at least 18 years of age

have histologically confirmed stage I-III breast cancer,

have completed adjuvant taxane-based chemotherapy (alone or in combination), ,

have an Eastern Cooperative Oncology Group performance status of 0 or 1, and reported grade 1 or greater CIPN symptoms for more than 2 weeks as defined by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE), version 4.03.

5 exclusion criteria prevent from participating
concurrent chemotherapy (there were no limitations on time from the last paclitaxel administration),

having metastatic or recurrent disease,

history of preexisting peripheral neuropathy prior to chemotherapy,

uncontrolled seizure disorder,

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Massachusetts General Hospital

Charlestown, United StatesOpen Massachusetts General Hospital in Google Maps
Recruiting
One Study Center